European Society of Cardiology (ESC) Congress 2023

European Society of Cardiology (ESC) Congress 2023

Amsterdam, The Netherlands

Semaglutide scores again, this time for HFpEF in obese
Semaglutide scores again, this time for HFpEF in obese
03 Oct 2023 byElvira Manzano

Once weekly injection of semaglutide causes weight loss in obese patients with heart failure with preserved ejection fraction (HFpEF), with positive shifts in symptoms and improvements in physical limitations in the STEP-HFpEF trial presented at ESC 2023.

Semaglutide scores again, this time for HFpEF in obese
03 Oct 2023
Extended anticoagulation benefits cancer patients with distal DVT
Extended anticoagulation benefits cancer patients with distal DVT
20 Sep 2023 byAudrey Abella

In cancer patients with isolated distal deep vein thrombosis (IDDVT), a 12-month anticoagulation regimen with the oral factor Xa inhibitor edoxaban fared better than a 3-month regimen, findings from the ONCO DVT study have shown.

Extended anticoagulation benefits cancer patients with distal DVT
20 Sep 2023
HEART-FID confirms IV iron safety for HF but falls short in efficacy
HEART-FID confirms IV iron safety for HF but falls short in efficacy
11 Sep 2023